Crescent Biopharma, Inc. (CBIO) stock
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$12.40−0.64 (-4.91%)
Close on Nov 18, 2026Market cap $460.59MP/E –Yield –
Crescent Biopharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Crescent Biopharma's revenue for the twelve months ending Dec 31, 2022 was $75.00K, down 93.5% year over year. For fiscal 2025 it was $10.84M, up 108340.0% from the year before. The highest annual figure on record is $20.07M in fiscal 2015.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.84M | +108340.0% |
| FY2023 | Dec 31, 2023 | $10.00K | -86.7% |
| FY2022 | Dec 31, 2022 | $75.00K | -93.5% |
| FY2021 | Dec 31, 2021 | $1.16M | -88.6% |
| FY2020 | Dec 31, 2020 | $10.16M | +54834.8% |
| FY2016 | Dec 31, 2016 | $18.50K | -99.9% |
| FY2015 | Dec 31, 2015 | $20.07M | +33.6% |
| FY2014 | Dec 31, 2014 | $15.03M | +276.4% |
| FY2013 | Dec 31, 2013 | $3.99M | -73.8% |
| FY2012 | Dec 31, 2012 | $15.26M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $1.04M | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $75.00K | -92.9% |
| Q4 FY2021 | Dec 31, 2021 | $17.63K | -89.2% |
| Q3 FY2021 | Sep 30, 2021 | $86.56K | -91.3% |
| Q2 FY2021 | Jun 30, 2021 | $142 | – |
| Q1 FY2021 | Mar 31, 2021 | $1.06M | -88.3% |
| Q4 FY2020 | Dec 31, 2020 | $162.94K | – |
| Q3 FY2020 | Sep 30, 2020 | $1.00M | +5305.4% |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $9.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $18.50K | – |
See a number that looks wrong?